Adaptive Biotechnologies (ADPT) Debt Ratio (2022 - 2026)

Adaptive Biotechnologies has disclosed Debt Ratio across 5 years of filings, most recently posting 0.26 for Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.26, down 1.3% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.26 (down 1.3% YoY), and the FY2025 annual result was 0.26, up 3.56% from the prior year.
• Debt Ratio came in at 0.26 for Q1 2026 at Adaptive Biotechnologies, up from 0.26 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.27 in Q2 2025 to a low of 0.15 in Q4 2022.
• The 5-year median for Debt Ratio is 0.24 (2024), against an average of 0.23.
• Across the five-year window, Debt Ratio jumped 35.05% in 2023 and fell 1.3% in 2026, its largest moves.
• Adaptive Biotechnologies' Debt Ratio stood at 0.15 in 2022, then surged by 35.05% to 0.2 in 2023, then climbed by 25.03% to 0.25 in 2024, then advanced by 3.56% to 0.26 in 2025, then climbed by 0.84% to 0.26 in 2026.
• The last three Debt Ratio figures came in at 0.26 (Q1 2026), 0.26 (Q4 2025), and 0.27 (Q3 2025), per Business Quant data.